← Back to Search

Dual-Task Gait for Neurologic Gait Disorders (MS Trial)

N/A
Waitlist Available
Led By Gregory Brusola, PT,DPT,MSCS
Research Sponsored by Texas Woman's University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up week 1, week 2, week 5, week 8, week 12
Awards & highlights

MS Trial Summary

This trial will test a new performance measure for people with MS who have trouble with both cognition and motor skills. The study will also test whether a gait-specific intervention can help these individuals walk better.

Eligible Conditions
  • Neurologic Gait Disorders
  • Cognitive Impairment
  • Multiple Sclerosis

MS Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~week 1, week 2, week 5, week 8, week 12
This trial's timeline: 3 weeks for screening, Varies for treatment, and week 1, week 2, week 5, week 8, week 12 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in Walking and Remembering Test
Secondary outcome measures
Change in 12-Item Multiple Sclerosis Walking Scale
Change in 2-Minute Walk Test
Change in Fatigue Scale for Motor and Cognitive Functions
+3 more
Other outcome measures
Changes in Borg Rating of Perceived Exertion
Changes in Visual Analog Scale for Fatigue

MS Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Dual-Task GaitExperimental Treatment1 Intervention
The Dual-Task Gait group will be provided with gait training AND secondary cognitive tasks during gait training.
Group II: Single-Task GaitActive Control1 Intervention
The Single-Task Gait group will be provided with gait training without the Dual-Task cognitive tasks.

Find a Location

Who is running the clinical trial?

Texas Woman's UniversityLead Sponsor
86 Previous Clinical Trials
5,800 Total Patients Enrolled
TIRR Memorial HermannOTHER
15 Previous Clinical Trials
4,675 Total Patients Enrolled
The University of Texas Health Science Center, HoustonOTHER
905 Previous Clinical Trials
321,030 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Measurement and Training of Dual-Task of Gait in Persons With Multiple Sclerosis
2018. "Measurement and Training of Dual-Task of Gait in Persons With Multiple Sclerosis". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03536299.
All > Primary Progressive Multiple Sclerosis
~12 spots leftby May 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top